First Eagle Investment Management, LLC - CONSTELLATION PHARMCETICLS I ownership

Quarter-by-quarter ownership
First Eagle Investment Management, LLC ownership history of CONSTELLATION PHARMCETICLS I
ValueSharesWeighting
Q2 2019$350,000
-79.3%
28,464
-77.2%
0.00%
-80.0%
Q1 2019$1,694,000
+238.1%
125,0000.0%0.01%
+400.0%
Q4 2018$501,000125,0000.00%
Other shareholders
CONSTELLATION PHARMCETICLS I shareholders Q3 2023
NameSharesValueWeighting ↓
Ponoi II Management, LLC 1,574,229$45,338,00033.03%
Ponoi Management, LLC 1,880,623$54,162,00030.99%
VR Adviser, LLC 4,016,873$115,686,00017.01%
Column Group LLC 2,626,631$75,647,0006.86%
COMMODORE CAPITAL LP 423,708$12,203,0006.64%
GREAT POINT PARTNERS LLC 1,024,800$29,514,0004.79%
Venrock Management V, LLC 1,557,276$44,850,0004.23%
Ghost Tree Capital, LLC 625,000$18,000,0004.01%
Euclidean Capital LLC 554,325$15,965,0003.38%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 737,406$21,237,0003.07%
View complete list of CONSTELLATION PHARMCETICLS I shareholders